Suurbritannias vaktsineeritud inimesed (1st dose): 52,399,031

People Vaccinated in the UK (2nd dose): 48,520,906

The Moderna COVID-19 vaccine was developed by the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and Moderna (an American pharmaceutical and biotechnology company).

It was the third COVID-19 vaccine to be approved by the UK’s Medicines and Healthcare products Regulatory Agency. The decision was made with advice from the Commission on Human Medicines (CHM), the government’s independent expert scientific advisory body.

mRNA (part of virus genetic code)
NHSi kättesaadavus
Approved but not available until Spring
-20C up to 6 months
MHRA heakskiit

8 January 2021

How does the Moderna COVID-19 vaccine work in the body when taken?

The Moderna COVID-19 Vaccine jabs are known as a messenger RNA (mRNA) vaccine. It uses synthetically produced genetic material called mRNA, which encodes the instructions to produce the SARS-CoV-2 (COVID-19) spike protein (the part of the virus that allows it to enter human cells).

The injection inserts this mRNA into the body. This then enters cells, which read the genetic code and start producing the virus protein – thus triggering a response by the immune system and coaching it to fight a future infection.

The mRNA molecule is not injected directly into the body, but is wrapped in oily bubbles made of lipid nanoparticles, to prevent our natural enzymes from breaking it down.

The jab uses mRNA produced in the lab by a template DNA, and doesn’t use a virus, unlike conventional vaccines which are produced using weakened forms of the virus. This can make the rate at which it can be produced or modified dramatically accelerated.

What are the ingredients of the Moderna COVID-19 vaccine?

This vaccine contains polyethylene glycol/macrogol (PEG) as part of PEG2000-DMG.

Teised koostisosad on:

Lipiid SM-102




Trometamool (Tris)



Trometamoolvesinikkloriid (Tris HCl)

1,2-dimüristoüül-rac-glütsero-3-metoksüpolüetüleenglükool-2000 (PEG2000-DMG)

1,2-distearoüül-sn-glütsero-3-fosfokoliin (DSPC)

How is the Moderna COVID-19 vaccine administered?

Vaktsiini manustatakse inimestele ainult turvalises tervishoiukeskkonnas, kus on olemas võimalused allergiliste reaktsioonide raviks, kui need ilmnevad. Ärge võtke vaktsiini kelleltki teiselt. Kui keegi seda pakub ja teil on kahtlusi, pöörduge oma perearsti poole.

This vaccine is injected into a muscle in your upper arm.

It will be given to you as two 0.5 mL injections. It is recommended to administer the second dose 28 days after the first.

When the Moderna vaccine is given for the first injection, the same vaccine should be given for the second injection to complete the vaccination course.

Iga vaktsiini süstimise ajal ja pärast seda jälgib teie arst, apteeker või meditsiiniõde teid umbes 15 minutit, et jälgida allergilise reaktsiooni nähte.

Are there any possible risks and/or side effects of the Moderna COVID-19 vaccine?

Miski meditsiinis ei kaasne riskideta - isegi miski, mida me mõtlemata võtame, näiteks paratsetamool, võib ohtu kujutada.

Like all medicines, this vaccine can cause side effects, although not everybody gets them. Most side effects go away within a few days of appearing. If side effects such as pain and/or fever are troublesome, they can be treated by medicines for pain and fever such as paracetamol.

You may very rarely experience a severe allergic reaction after receiving this vaccine. Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency department right away if you have an allergic reaction. It can be life-threatening.


Kõrvaltoimete hulka võivad kuuluda:

Väga sage (võib mõjutada rohkem kui 1 inimest 10-st)







Pain or swelling at the injection site

Muscle ache, joint swelling and stiffness

Tenderness and swelling of the underarm glands on the same side as the injection site

Sage (võib mõjutada kuni 1 inimest 10-st)


Rash, redness, or hives at the injection site

Aeg-ajalt (võib mõjutada kuni 1 inimest 100-st)

Itchiness at the injection site

Rare (may affect up to 1 in 1000 people)

Temporary one-sided facial drooping (Bell’s palsy)

Swelling of the face (Swelling of the face may occur in patients who have had facial cosmetic injections)

Frequency unknown

Severe allergic reactions (anaphylaxis)


Hoiatused ja ettevaatusabinõud

Enne selle vaktsiini manustamist pidage nõu oma arsti, apteekri või meditsiiniõega, kui:

Have any allergies. If you have experienced a severe allergic reaction after the first dose of this vaccine, you should not receive a second dose.

Have a very weak or compromised immune system, for example, due to HIV infection, or you are taking a medicine that affects your immune system.

Have a bleeding problem, bruise easily or use a medicine to inhibit blood clotting.

Have a high fever or severe infection. However, a mild fever or upper airway infection, like a cold, are not reasons to delay vaccination.

Have any serious illness.

ÄRGE vaktsiini võtke, kui

you are allergic to the active substance or any of the other ingredients of this vaccine


இதை பகிர்